Literature DB >> 2879584

Prejunctional beta-adrenoceptors in rabbit pulmonary artery and mouse atria: effect of alpha-adrenoceptor blockade and phosphodiesterase inhibition.

H Johnston, H Majewski.   

Abstract

In rabbit isolated pulmonary artery previously incubated with [3H]-noradrenaline, isoprenaline (0.3 microM) had no effect on the stimulation-induced outflow of radioactivity. However, if the phosphodiesterase inhibitor ICI 63,197 (30 microM) or the alpha-adrenoceptor blocker phentolamine (1 microM) was present, then isoprenaline significantly enhanced the stimulation-induced outflow, an effect blocked by propranolol (0.1 microM). ICI 63,197 (30 microM) but not phentolamine significantly enhanced the stimulation-induced outflow of radioactivity. In mouse isolated atria previously incubated with [3H]-noradrenaline and stimulated at a frequency of 10 Hz, isoprenaline had no effect on the stimulation-induced outflow of radioactivity; this is in contrast to its release-enhancing effects at stimulation frequencies of 4 Hz and 2 Hz. The facilitation of stimulation-induced outflow by isoprenaline at 4 Hz was blocked by propranolol (0.08 microM) which, by itself, had no effect on the stimulation-induced outflow. At a stimulation frequency of 2 Hz in mouse atria the facilitatory effect of isoprenaline (0.01 microM) was significantly greater in the presence of ICI 63,197 (30 microM) which, by itself, had no effect on the stimulation-induced outflow. Similarly, the facilitatory effect of isoprenaline was significantly greater in the presence of phentolamine (1 microM) but, in this case, phentolamine significantly enhanced the stimulation-induced outflow. These results suggest that facilitatory prejunctional beta-adrenoceptors are present in both rabbit pulmonary artery and mouse atria. The effects of the phosphodiesterase inhibitor ICI 63,197 suggest that they are linked to adenylate cyclase in both tissues and we propose that the ability of phentolamine to facilitate the release and enhance the effect of isoprenaline may be due to the blockade of alpha-adrenoceptor inhibition of adenylate cyclase. This latter proposition needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879584      PMCID: PMC1916557          DOI: 10.1111/j.1476-5381.1986.tb10197.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Biphasic effect of the alpha-adrenolytic phentolamine on hormone-stimulated formation of cyclic adenosine-3',5'-monophosphate in isolated fat cells of rats.

Authors:  K Stock; T Thomas
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

2.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

3.  Enhanced release of dopamine -hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3', 5'-monophosphate and theophylline.

Authors:  G F Wooten; N B Thoa; I J Kopin; J Axelrod
Journal:  Mol Pharmacol       Date:  1973-03       Impact factor: 4.436

4.  The effect of phentolamine and other drugs on rat brain phosphodiesterase.

Authors:  J H McNeill; C Y Lee; L D Muschek
Journal:  Can J Physiol Pharmacol       Date:  1972-08       Impact factor: 2.273

5.  Influence of alpha- and beta-adrenoceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices.

Authors:  L O Farnebo; B Hamberger
Journal:  J Pharm Pharmacol       Date:  1974-08       Impact factor: 3.765

6.  Effects of forskolin in rat vas deferens--evidence for facilitatory beta-adrenoceptors.

Authors:  D Hovevei-Sion; J P Finberg; A Bomzon; M B Youdim
Journal:  Eur J Pharmacol       Date:  1983-11-25       Impact factor: 4.432

7.  The noradrenaline rate in the anaesthetized rabbit: facilitation by adrenaline.

Authors:  H Majewski; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

8.  Effects of alpha- and beta-adrenoceptor agonists and a phosphodiesterase inhibitor (ICI 63 197) on cyclic AMP and GMP levels in bovine splenic nerve.

Authors:  Z Merican; M W Nott
Journal:  Clin Exp Pharmacol Physiol       Date:  1983 Jan-Feb       Impact factor: 2.557

9.  Effect of desipramine on propranolol-induced diminution of noradrenaline release by nerve stimulation.

Authors:  E Adler-Graschinsky; A H Carrara
Journal:  J Cardiovasc Pharmacol       Date:  1982 Nov-Dec       Impact factor: 3.105

10.  Local modulation of noradrenaline release in vivo: presynaptic beta 2-adrenoceptors and endogenous adrenaline.

Authors:  H H Schmidt; C Schurr; L Hedler; H Majewski
Journal:  J Cardiovasc Pharmacol       Date:  1984 Jul-Aug       Impact factor: 3.105

View more
  16 in total

1.  Effect of isoprenaline on noradrenaline release from sympathetic neurones in rabbit isolated pulmonary artery.

Authors:  O A Nedergaard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues.

Authors:  A U Trendelenburg; S L Cox; V Schelb; W Klebroff; L Khairallah; K Starke
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Lack of presynaptic modulation by isoprenaline of 3H-noradrenaline release from rabbit isolated ear artery.

Authors:  J Abrahamsen; O A Nedergaard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

4.  Beta-adrenoceptor-mediated facilitation of [3H]-noradrenaline release from the intramural nerves of bovine mesenteric lymphatic vessels.

Authors:  J M Allen; J G McCarron; N G McHale; K D Thornbury
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

5.  Role of cyclic AMP in the release of noradrenaline from isolated rat atria. Effect of pretreatment with clenbuterol.

Authors:  M G Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

6.  Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria.

Authors:  H Johnston; H Majewski; I F Musgrave
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

7.  Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.

Authors:  Anikó Kovács; János Magyar; Tamás Bányász; Péter P Nánási; Gábor Szénási
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Facilitation of noradrenaline release from sympathetic nerves in rat anococcygeus muscle by activation of prejunctional beta-adrenoceptors and angiotensin receptors.

Authors:  C G Li; H Majewski; M J Rand
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

9.  Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, beta-adrenoceptors and angiotensin II receptors.

Authors:  M Costa; H Majewski
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

10.  Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog.

Authors:  S Foucart; R Nadeau; J de Champlain
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.